Project Name：Propanediol hydrochloride and cephalosporin formulations song 

Registration Classification：3.1

Formulations and specifications ：Capsules, 250mg, 500mg. Oral, 5%, 500mg per 5ml. 

Indications：The lungs caused by Staphylococcus aureus, Streptococcus pneumoniae , E. coli and other sensitive strains , intestinal , urinary and soft tissue infections , such as cystitis , pyelonephritis, pharyngitis and tonsillitis .

Original Research Company：Bristol-Myers Squibb launched in Japan 

Progress ：Pharmaceutical Research in progress